Best GLP-1 for Sleep Apnea: Zepbound Is the Only FDA-Approved Option
By The RX Index Research Team · Last verified:
The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers. Some links on this page are affiliate links. That never decides our pick—for sleep apnea, the winner is the only FDA-approved drug for the condition, not whichever company pays us most.
This page is for education and comparison. It is not medical advice. A licensed doctor decides if any medication is right for you. Do not stop using a CPAP machine or change your sleep apnea treatment without talking to your clinician.
If you’ve heard that one of those weight-loss shots can now treat sleep apnea, you heard right—but only one of them, and not the one most people guess. The best GLP-1 for sleep apnea is Zepbound (tirzepatide). It’s the only medicine the FDA has approved to treat moderate-to-severe obstructive sleep apnea in adults who also have obesity, approved in December 2024. Ozempic, Wegovy, Mounjaro, and compounded versions are not.
There is one thing about your CPAP machine that most coverage-check pages skip. We’ll get to it. First, here’s the fast answer for your exact situation.
| If this is you… | Best path | Why |
|---|---|---|
| “I just want the GLP-1 that’s actually approved for sleep apnea” | Zepbound (tirzepatide) | The only FDA-approved drug for moderate-to-severe OSA with obesity |
| “I have a plan and want help checking if it’s covered” | Ro (sponsored affiliate link, opens in a new tab) | Free coverage checker + a team that handles insurance paperwork |
| “I’d rather pick my own doctor and do a video visit” | Sesame (sponsored affiliate link, opens in a new tab) | Doctor marketplace, video visits, refills, can help with paperwork |
| “I already have a prescription” | LillyDirect (sponsored affiliate link, opens in a new tab) | Maker-direct cash price, often the lowest |
| “I’m not sure I can stop my CPAP” | A sleep doctor | CPAP decisions need a clinician—usually a repeat sleep test |
| “I want compounded tirzepatide for sleep apnea” | Not a fit | Compounded versions are not FDA-approved for OSA |
Before you check coverage: Do you have a sleep study showing OSA? Do you know your AHI score? Do you have your insurance card handy? If yes to all three, a coverage check is your fastest next step. If not, start with a sleep doctor—we’ll point you there below.
Check whether your insurance covers Zepbound for sleep apnea
Free coverage report through Ro. Your medication cost and Ro’s membership are separate, and a doctor decides if you qualify.
(sponsored) · Ro's free coverage checker. A licensed doctor decides if you qualify.
Three things people assume—and what’s actually true
| What people assume | What’s actually true |
|---|---|
| “Any GLP-1 or Ozempic treats sleep apnea” | Only Zepbound is FDA-approved for it |
| “I can drop my CPAP once I start the shot” | The studies didn’t test that—your doctor decides, usually after a repeat sleep test |
| “Medicare covers it at $50/month for sleep apnea” | The $50 program is for weight loss only; sleep apnea runs through your regular Part D plan |
What we verified on
We don’t ask you to take our word for it. Here’s what we checked, where it came from, and what to re-confirm before you act (prices and policies move fast).
| Claim | What’s true now | Source |
|---|---|---|
| FDA approval | Zepbound approved for moderate-to-severe OSA in adults with obesity (Dec. 20, 2024) | FDA; Eli Lilly |
| The trial | SURMOUNT-OSA—two 52-week studies in 469 adults with moderate-to-severe OSA and obesity | Zepbound prescribing data; NEJM (2024) |
| The numbers | Breathing interruptions dropped ~25/hour (no-CPAP group) and ~29/hour (CPAP group), vs. ~5–6 on placebo | Zepbound clinical data |
| Dosing | Starter dose is 2.5 mg; the dose that treats apnea is 10 mg or 15 mg weekly | Eli Lilly Medical |
| Self-pay price | LillyDirect: $299 (2.5 mg), $399 (5 mg), $449 (7.5–15 mg) with the 45-day refill rule; $499 (7.5 mg), $699 (10/12.5/15 mg) otherwise | LillyDirect terms |
| Medicare | Covered through regular Part D for sleep apnea (not the $50 weight-loss Bridge); plan rules and prior authorization apply | CMS |
| Commercial insurance | CVS Caremark adding Zepbound back to commercial formularies as preferred option on Oct. 1, 2026 | CVS Health (May 28, 2026) |
What is the best GLP-1 for sleep apnea in 2026?
The best GLP-1 for sleep apnea is Zepbound, the brand name for tirzepatide. It is the only medication the FDA has approved to treat moderate-to-severe obstructive sleep apnea (OSA) in adults who also have obesity. Ozempic, Wegovy, Mounjaro, Foundayo, and compounded tirzepatide are not approved for sleep apnea, even though some of them are approved for weight loss or diabetes.
Quick definition, because it trips people up. Obstructive sleep apnea (OSA) is when the soft tissue in your throat relaxes and blocks your airway while you sleep. You stop breathing for a few seconds, your brain jolts you just enough to start again, and this can happen dozens or even hundreds of times a night—usually without you knowing. That’s why you wake up tired no matter how long you slept.
A small but honest correction on the search term itself. People type “GLP-1 for sleep apnea,” so we use that phrase too. But Zepbound isn’t a pure GLP-1 drug. It’s a dual GIP/GLP-1 receptor agonist—meaning it works on two gut hormones at once, not one. For your decision, the simple truth is what matters: the drug is Zepbound, and it’s the only one approved for this.
Who Zepbound is approved for
The FDA approval is specific. It’s for adults who have all of these:
- Moderate-to-severe obstructive sleep apnea (confirmed by a sleep study)
- Obesity
- A plan to also eat fewer calories and move more
Who this page is probably not for
We’d rather lose you here than waste your time. Zepbound for sleep apnea likely isn’t your answer if:
- You have mild sleep apnea, or you haven’t had a sleep study yet. Your first step is a diagnosis, not a shot.
- You’re at a healthy weight and just want something for snoring or light apnea.
- You’re hoping to quietly stop your CPAP on your own. Please don’t—we’ll explain why below.
- You’re shopping for the cheapest “compounded” version and assuming it’s the same thing. It isn’t, and it isn’t approved for sleep apnea.
- You have a personal or family history of medullary thyroid cancer or a genetic condition called MEN 2. Zepbound is not for you—full stop. More on safety below.
How the GLP-1 family stacks up for sleep apnea
| Medication | FDA-approved for sleep apnea? | What it’s actually for |
|---|---|---|
| Zepbound (tirzepatide) | Yes—the only one | Moderate-to-severe OSA with obesity |
| Wegovy (semaglutide) | No | Weight management; cardiovascular risk reduction |
| Ozempic (semaglutide) | No | Type 2 diabetes |
| Mounjaro (tirzepatide) | No | Type 2 diabetes (same active ingredient as Zepbound, different approved use) |
| Foundayo (orforglipron) | No | Weight management (oral) |
| Compounded GLP-1 versions | No | Not FDA-approved for sleep apnea |
How well does Zepbound actually work for sleep apnea?
In the trials that earned the FDA approval, Zepbound cut breathing interruptions dramatically. People not using a CPAP machine had about 25 fewer interruptions per hour. People using a CPAP machine had about 29 fewer per hour. Placebo barely moved the needle at 5–6 fewer per hour. These were one-year studies in adults with obesity, and the FDA says the improvement is tied to the weight people lost.
The apnea-hypopnea index (AHI) is the number of times each hour your breathing stops or gets very shallow while you sleep. Doctors use it to size up severity:
- AHI 15 to 30 = moderate
- AHI 30 or higher = severe
If you start at an AHI of 50 (severe) and drop it by 25, you’ve roughly cut your nighttime breathing problems in half. That’s the difference between gasping every minute and breathing through most of the night.
What the SURMOUNT-OSA trials found
| Study | Who was in it | Breathing interruptions cut (per hour) | vs. placebo | Average weight lost |
|---|---|---|---|---|
| Study 1 | Adults not using a CPAP machine | About 25 fewer | About 5 fewer | About 45 lb (18%) |
| Study 2 | Adults on a CPAP machine | About 29 fewer | About 6 fewer | About 50 lb (20%) |
After one year, 42% of people not on CPAP, and 50% of people on CPAP, saw their sleep apnea go away or drop to a mild, symptom-free level. On placebo, that was 16% and 14%.
What these numbers do—and don’t—promise
These were strong results. But they were averages, over 52 weeks, in adults with obesity and moderate-to-severe apnea. They do not mean everyone gets the same result. They do not mean the apnea is gone for good. And—this is the big one—the studies were not designed to tell you when it’s safe to put your CPAP machine in the closet.
Can Zepbound replace your CPAP machine?
No reputable source will tell you to swap your CPAP machine for Zepbound on your own. Zepbound can lower how severe your sleep apnea is, sometimes a lot. But the trials did not study when or whether it’s safe to stop CPAP, so that decision belongs to your doctor—usually after a repeat sleep test shows your apnea has actually improved.
Zepbound is the best medication answer for sleep apnea—but it is not a do-it-yourself plan to quit your CPAP. If you were hoping this page would say “take the shot and ditch the mask,” we can’t, and any page that does is putting clicks ahead of your safety.
If you already use a CPAP machine
- Keep using it until your doctor says otherwise.
- Ask whether you’ll need a repeat sleep test after you lose weight.
- Ask if your machine’s pressure settings should be adjusted.
- Notice changes in daytime sleepiness and snoring—but don’t decide you’re “cured” on your own.
One important detail: in Study 2, the people who did best were CPAP users who took Zepbound and kept their machine. To measure the drug’s true effect, the study had them pause CPAP for about a week before the final breathing test. That’s a sign of careful, doctor-managed care—not a green light to stop CPAP on your own.
If you can’t tolerate your CPAP
Plenty of people hate the mask. If you have obesity and moderate-to-severe apnea, Zepbound may be a real path forward. But a sleep doctor can also talk through other options—oral appliances, different masks, positional therapy, or another sleep test.
Already diagnosed with OSA?
Run a free Zepbound coverage check before you pay cash. It tells you if your plan might cover it—without changing anything about your CPAP.
Who qualifies for Zepbound for sleep apnea?
The FDA approval is for adults with obesity and moderate-to-severe obstructive sleep apnea. In real life, whether you get it—and whether insurance pays—usually depends on your sleep study, your AHI score, your weight history, your other health conditions, and a doctor agreeing it’s right for you.
Bring this to your doctor or telehealth visit
- Your sleep study report (showing you have OSA)
- Your AHI score and whether it’s moderate or severe
- Your height, weight, and BMI
- Your weight history and past weight-loss attempts (some plans require this)
- Your CPAP history—using it, struggling with it, or not tolerating it
- Other conditions like high blood pressure or type 2 diabetes
- A full list of your current medications
- Your insurance card
Quick term: BMI (body mass index) is a number from your height and weight doctors use as a rough stand-in for body fat. Obesity generally starts at a BMI of 30.
What if you have mild sleep apnea?
The approval is built around moderate-to-severe apnea. If yours is mild, the better next step is a conversation with a sleep doctor or your primary care provider.
What if you have obesity but no sleep study yet?
Then a sleep study is step one. You can’t get the sleep apnea approval without a diagnosis, and a sleep test is how you find out how serious it is.
Not sure where you stand?
Take our free 60-second GLP-1 match quiz and get a simple checklist of what to ask your doctor.
How much does Zepbound cost for sleep apnea in 2026?
The lowest self-pay price starts around $299 a month for the starter dose through LillyDirect, and rises with your dose. A regular pharmacy lists brand pens near $1,086 a month before insurance or savings. Telehealth services like Ro and Sesame charge a separate care or membership fee on top of the medication. If insurance covers it, your cost can drop far below any cash price.
| Route | Medication cost | Care / membership fee | Best for |
|---|---|---|---|
| LillyDirect (sponsored affiliate link, opens in a new tab) (self-pay vials) | $299 (2.5 mg), $399 (5 mg), $449 (7.5–15 mg) with 45-day refill rule; $499 (7.5 mg), $699 (10/12.5/15 mg) otherwise | None by default | You already have a prescription |
| Ro (sponsored affiliate link, opens in a new tab) | Zepbound matched to maker pricing; starts at $299 first month | $39 first month, then as low as $74/month (annual) | You want insurance help + online care |
| Sesame (sponsored affiliate link, opens in a new tab) | Zepbound vials from $299/month (LillyDirect parity); billed separately | $99/month, or as low as $59/month (annual) | You want to choose your own doctor |
| Regular pharmacy (brand pen) | ~$1,086/month list before insurance or savings | — | Usually not the cash-pay baseline to beat |
The 45-day refill rule. LillyDirect’s lowest prices on higher doses depend on refilling within 45 days. Miss that window, and the price jumps to $499 (7.5 mg) or $699 (10/12.5/15 mg). Set a reminder around day 30.
$299 is the starter dose, not the working dose. The dose that treats sleep apnea is 10 mg or 15 mg a week. Through LillyDirect, that’s $449/month with the refill rule, or $699/month otherwise. Budget for the maintenance dose. See our Zepbound savings card and LillyDirect price guide for the full dose-by-dose breakdown.
The biggest lever isn’t the cash price—it’s insurance
Coverage can change the real number completely.
Will insurance cover Zepbound for sleep apnea?
Commercial insurance may cover Zepbound for sleep apnea, but it’s plan-by-plan and almost always requires prior authorization. The sleep apnea diagnosis is your strongest case, because no other GLP-1 is FDA-approved for it.
Prior authorization (PA) is when your insurance makes your doctor show documentation—your diagnosis, your AHI, your weight—before they agree to pay. For sleep apnea you actually have a strong case.
- Coverage depends on your specific plan.
- Expect a prior authorization request.
- Your sleep study and AHI severity matter a lot.
- So does your obesity diagnosis.
- Denials happen—and they’re often worth appealing.
In May 2026, CVS Caremark announced it’s adding Zepbound back to its commercial formularies as a preferred option starting Oct. 1, 2026. Your employer still chooses whether to follow CVS’s standard list. And if your plan steers you to Wegovy, remember: Wegovy is not approved for sleep apnea. For OSA, there’s no equal swap—a strong reason to ask for a coverage exception.
Your prior-authorization checklist
- Sleep study report
- AHI score and severity (moderate or severe)
- BMI and obesity diagnosis
- CPAP history
- Weight-related conditions and past treatments
- Current medications
- Insurance card
- Any denial letter you’ve already received
The common diagnosis code for obstructive sleep apnea is G47.33. Your doctor or biller handles the actual coding. More in our guide to obesity and OSA ICD-10 codes for GLP-1 prior authorization.
If you get denied, ask this
“Was this denied because of a weight-loss exclusion, missing sleep apnea documentation, a missing AHI severity, a missing obesity diagnosis, or a step-therapy rule?”
The answer tells you exactly what to fix for an appeal.
Have commercial insurance?
Run Ro’s free GLP-1 Insurance Coverage Checker before you commit a dollar.
Does Medicare cover Zepbound for sleep apnea?
Yes—Medicare can cover Zepbound for sleep apnea through your regular Part D drug plan. Moderate-to-severe OSA with obesity is a Part D-covered medical reason (not weight loss alone). Normal plan rules apply. This is a different door from the new Medicare GLP-1 Bridge.
- Regular Part D (your path for sleep apnea). CMS says sleep apnea is one of the medical reasons covered under standard Part D. Your cost depends on your plan’s formulary and copay, and you’ll likely need prior authorization with your sleep study on file.
- The Medicare GLP-1 Bridge (not your path for sleep apnea). This temporary program runs July 2026 through December 2027, with a flat $50/month copay—but only for GLP-1s prescribed for weight management. CMS is explicit: people prescribed a GLP-1 for sleep apnea get it through their Part D plan and are not eligible for the Bridge.
For sleep apnea, your real number depends on your Part D plan. Check your plan’s drug list (formulary), call your plan, or ask your pharmacist about prior authorization. Our full Medicare and Zepbound coverage guide walks through the Part D steps.
On Medicare? Read our Zepbound Medicare coverage guide first, then check your Part D formulary or ask your pharmacist about prior authorization. Ro’s free checker is built for commercial insurance, not Medicare.
Where should you get Zepbound? Ro vs. Sesame vs. LillyDirect vs. a sleep doctor
The medication winner is the same for everyone—Zepbound. But the best place to get it changes with your situation. Ro is the strongest starting point if insurance is your hurdle. Sesame fits if you want to choose your own doctor. LillyDirect is cleanest if you already have a prescription. And a sleep doctor is the right call if your diagnosis or CPAP plan is unclear.
Best starting point for most people: Ro
If your biggest obstacle is “I don’t even know if my plan covers this,” Ro is built for you. It carries FDA-approved Zepbound, gives you a free insurance coverage checker (sponsored affiliate link, opens in a new tab), and has an insurance team that handles the prior-authorization paperwork—the exact thing that trips people up.
Honest admission: Ro is not free. There’s a membership fee ($39 the first month, then as low as $74/month annual), separate from the medication. But because Ro charges for care, you get the coverage checker and the team that works the insurance paperwork on your behalf. When the entire game is getting Zepbound covered for sleep apnea, that’s often worth more than saving a membership fee. Read our Ro GLP-1 review.
Start your Zepbound coverage check with Ro
Free coverage report, FDA-approved medication, and a team that handles the insurance paperwork. A doctor decides if you qualify.
Best if you want to choose your doctor: Sesame
Prefer to pick a specific provider and do a video visit instead of a membership-first experience? Sesame’s Success by Sesame is a doctor marketplace with video visits, refills, and providers who can help with prior authorization. Care plan: $99/month, or as low as $59/month annual; medication billed separately from $299/month. Read our Sesame GLP-1 review.
Prefer to pick your own provider? Compare Zepbound visits on Sesame.
Best if you already have a prescription: LillyDirect
If you’ve already got a doctor and a prescription and you just need the medication at the lowest honest price, go straight to the source. LillyDirect is Eli Lilly’s own service, with self-pay Zepbound vials from $299 to $449 a month (with the 45-day refill rule) and no membership layer. The catch is it doesn’t manage your care or chase insurance for you.
Already have a prescription? Compare LillyDirect before paying a platform fee.
Best if you’re medically unsure: a sleep doctor
If you don’t know your AHI, you’re not sure whether your CPAP can change, or your apnea is complicated—see a sleep specialist or your regular doctor first. They can order a repeat sleep test, adjust CPAP, review your risks, and write the strongest documentation for coverage.
| Your situation | Best next step |
|---|---|
| Diagnosed moderate/severe OSA + obesity + commercial insurance | Ro (sponsored affiliate link, opens in a new tab) coverage checker |
| Diagnosed, want to choose your own doctor | Sesame (sponsored affiliate link, opens in a new tab) |
| Already have a Zepbound prescription | LillyDirect (sponsored affiliate link, opens in a new tab) |
| On Medicare | Check your Part D formulary + our Medicare guide |
| Mild apnea or no sleep study yet | Sleep doctor / primary care first |
| Want to stop CPAP on your own | Sleep doctor first—don’t do this alone |
| Want compounded tirzepatide for OSA | Not a fit—not approved for OSA |
| Not sure which box you’re in | Our free 60-second match quiz |
What about Ozempic, Wegovy, Mounjaro, Foundayo, or compounded versions?
For the question “best GLP-1 for sleep apnea,” the answer is still Zepbound, because it’s the only one the FDA approved for the condition. The others may be right for diabetes or weight loss, but none carry a sleep apnea approval.
Losing weight by almost any means tends to help sleep apnea. So you may read that semaglutide (Ozempic, Wegovy) “helps with apnea.” Indirectly, through weight loss, it might. But that’s different from a drug studied and approved specifically for sleep apnea. Only Zepbound clears that bar.
- Ozempic (semaglutide): Not approved for sleep apnea. It’s a diabetes drug.
- Wegovy (semaglutide): Not approved for sleep apnea. It’s for weight management and heart-risk reduction.
- Mounjaro (tirzepatide): Same active ingredient as Zepbound, but it’s the diabetes brand and not the FDA-approved sleep apnea product. Also: Zepbound should not be used together with other tirzepatide products or any other GLP-1 receptor agonist.
- Foundayo (orforglipron): An oral weight-loss option—not the sleep apnea answer. Ro carries it for weight-loss goals; for sleep apnea, the path is Zepbound.
A clear word on compounded tirzepatide
Compounded tirzepatide is not FDA-approved for obstructive sleep apnea, and we won’t recommend it as the “best GLP-1 for sleep apnea.”
“Compounded” drugs are mixed by a pharmacy, not tested by the brand manufacturer. The FDA declared the tirzepatide shortage resolved, and the temporary periods that allowed shortage-based compounding ended in 2025. Compounded tirzepatide is not approved for sleep apnea, and sleep-medicine organizations have specifically warned patients about it. For a serious condition with a real approved treatment, this isn’t the place to gamble.
Is Zepbound safe? Side effects and who should not take it
Zepbound is a powerful prescription drug with real risks. It carries a boxed warning about thyroid tumors and is off-limits for people with certain thyroid cancers or a genetic condition called MEN 2. The most common side effects are stomach-related—nausea, diarrhea, constipation—and there are rarer but serious risks your doctor will screen you for.
For a fuller rundown, see GLP-1 side effects and who should avoid them.
The boxed warning and who must avoid it
Zepbound carries the FDA’s strongest warning—a boxed warning—about thyroid C-cell tumors seen in animal studies. You should not take Zepbound if you or your family have a history of:
- Medullary thyroid carcinoma (MTC)—a rare thyroid cancer
- MEN 2 (Multiple Endocrine Neoplasia type 2)—a genetic condition
Also off-limits if you’ve had a serious allergic reaction to tirzepatide.
Common side effects
Most people who have side effects get stomach ones, usually worst when the dose goes up: nausea, vomiting, diarrhea, constipation, stomach pain, indigestion, burping, acid reflux. Some people also report injection-site reactions, tiredness, and hair loss. Severe vomiting or diarrhea can dehydrate you—drink fluids and call your doctor if it’s bad.
Rarer but serious risks to know
- Pancreatitis: severe belly pain, sometimes spreading to your back. Call your doctor.
- Gallbladder problems: Zepbound and fast weight loss can raise the risk.
- Low blood sugar: more likely if you also take insulin or certain diabetes pills.
- Kidney problems from dehydration: severe vomiting or diarrhea can cause fluid loss.
- Eye changes if you have diabetes: your doctor may monitor your eyes if you have a history of diabetic retinopathy.
- Severe gastroparesis: Zepbound isn’t recommended if you have this condition.
- Serious allergic reactions: rare, but possible.
Surgery and anesthesia
Because Zepbound slows stomach emptying, food can stay in your stomach longer—a risk during anesthesia. Tell any surgeon or anesthesiologist that you take Zepbound before any procedure.
Pregnancy and birth control
Tell your doctor if you’re pregnant, breastfeeding, or trying. Zepbound can make birth control pills work less well. If you use the pill, your doctor may suggest a backup method for four weeks after you start and after each dose increase. Never share a Zepbound KwikPen with anyone.
What to ask your doctor before you start
The right conversation isn’t just “can I lose weight?” It’s “does my sleep apnea documentation support this medication, and how will we treat my apnea safely?” Walk in with your sleep study, your weight history, and a short list of questions.
Copy these and bring them with you:
- “Does my sleep study show moderate or severe obstructive sleep apnea?”
- “Does my weight and BMI fit the Zepbound sleep apnea approval?”
- “Should I keep using my CPAP while I start?”
- “When would we repeat my sleep test?”
- “Do any side effects or contraindications apply to me?”
- “What insurance paperwork should we submit?”
- “If my plan denies it, what’s the appeal plan?”
- “What dose schedule would I follow?”
- “How will we track my weight, symptoms, and sleep?”
- “If I don’t qualify, what are my other options?”
For telehealth visits, upload: your sleep study, medication list, insurance card, weight history, CPAP notes, any denial letter, and recent lab work.
Want a personalized starting point?
Take our free 60-second GLP-1 match quiz and get a checklist made for your situation.
How we picked the best GLP-1 for sleep apnea
We ranked the options by one thing first: which drug is actually FDA-approved for sleep apnea. After that, we looked at ease of access, insurance help, clear pricing, and honest CPAP guidance. Affiliate payouts did not decide the winner.
| What we weighed | Weight |
|---|---|
| FDA-approved for sleep apnea | 35% |
| Fit for moderate-to-severe OSA with obesity | 20% |
| Insurance and prior-authorization help | 15% |
| Clear, verified pricing | 15% |
| Honest CPAP and safety guidance | 10% |
| Up-front about downsides | 5% |
We’d change the winner if another drug earns an FDA sleep apnea approval, Zepbound’s label changes significantly, or Ro/Sesame/LillyDirect changes pricing or insurance support. The RX Index may earn a commission from some providers on this page. That did not pick the medication.
Frequently asked questions
The short version: Zepbound is the only FDA-approved medication for moderate-to-severe sleep apnea in adults with obesity. What matters next is whether you qualify, whether insurance covers it, what it costs, and whether your CPAP should change.
- Which GLP-1 is approved for sleep apnea?
- Zepbound (tirzepatide) is the only medication the FDA has approved for moderate-to-severe obstructive sleep apnea in adults with obesity.
- Is tirzepatide a GLP-1?
- Tirzepatide works on two gut hormones, GIP and GLP-1, so people group it with GLP-1 drugs. More precisely, it is a dual GIP/GLP-1 receptor agonist.
- Is Zepbound approved for mild sleep apnea?
- No. The approval is for moderate-to-severe apnea. If yours is mild, talk to a sleep doctor about the best next step.
- Can Zepbound cure sleep apnea?
- Don’t assume a cure. It lowered apnea severity in trials, and many people saw it drop to mild or go into remission, but results vary and the studies did not show it is safe to stop CPAP on your own.
- Can I use Zepbound and my CPAP together?
- Yes. One of the approval studies included people using a CPAP machine, and that group did the best. Your doctor decides if your CPAP should change.
- How fast does Zepbound work for sleep apnea?
- The studies measured results over a full year. Improvement builds as you lose weight — this is not an overnight fix.
- Does insurance cover Zepbound for sleep apnea?
- Sometimes. It depends on your plan, prior authorization, your AHI severity, and your obesity diagnosis. The sleep apnea approval gives you a stronger case than weight loss alone.
- Does Medicare cover Zepbound for sleep apnea?
- Medicare can cover it through your regular Part D plan for the sleep apnea diagnosis, not for weight loss alone, with plan rules and prior authorization. This is separate from the Medicare GLP-1 Bridge, whose $50 copay applies only to GLP-1s prescribed for weight management — people with sleep apnea get coverage through Part D and are not eligible for the Bridge.
- Is Wegovy approved for sleep apnea?
- No. Wegovy is not FDA-approved for sleep apnea.
- Is Ozempic approved for sleep apnea?
- No. Ozempic is a diabetes medication and is not approved for sleep apnea.
- Is Mounjaro approved for sleep apnea?
- No. Mounjaro has the same active ingredient as Zepbound but it is the diabetes brand and is not the sleep apnea product. The brand and the approved use matter, not just the molecule.
- Is compounded tirzepatide approved for sleep apnea?
- No. Compounded tirzepatide is not FDA-approved for sleep apnea, and the FDA does not review these copies for safety or quality.
- What does Zepbound cost for sleep apnea without insurance?
- Self-pay starts around $299 per month for the starter dose through LillyDirect. The working dose for apnea is 10 mg or 15 mg, which runs $449 per month with the 45-day refill rule, or $699 per month at the regular price.
- What sleep apnea code do I need for insurance?
- The common diagnosis code for obstructive sleep apnea is G47.33. Your doctor or biller handles the coding from your records.
- What if my insurance denies Zepbound?
- Ask whether it was denied for a weight-loss exclusion, missing sleep apnea documentation, missing AHI severity, missing obesity diagnosis, or a step-therapy rule. Then ask your doctor about an appeal.
- Can Ro or Sesame prescribe Zepbound for sleep apnea?
- Both offer access to FDA-approved Zepbound. Ro gives you a free coverage report, and its membership includes insurance support and prior-authorization help if treatment is prescribed. Sesame’s providers can assist with prior-authorization paperwork. Neither can guarantee coverage, and a licensed provider must decide it is appropriate — generally, you will need a sleep study on file for the sleep apnea diagnosis specifically.
The bottom line
For “best GLP-1 for sleep apnea,” there’s one honest answer: Zepbound (tirzepatide), the only FDA-approved option for moderate-to-severe obstructive sleep apnea in adults with obesity. It works by helping you lose weight, the trial results were strong, and—said plainly—it is not a license to quit your CPAP on your own. If you’re diagnosed and want to know what it’ll cost, the smartest first move is a free coverage check. If you’re not sure where you stand, start with a sleep study or our quiz. You finally have a real, approved path. Now you know exactly how to walk it.
Still not sure which GLP-1 program is right for you?
Take our free 60-second matching quiz. Answer a few quick questions about your diagnosis, insurance, and goals, and we’ll point you to the right next step—Ro, Sesame, LillyDirect, or a sleep doctor—plus a checklist for your appointment.